regulatory
confidence high
sentiment negative
materiality 0.60
NextPlat Corp (NXPL): Nasdaq/NYSE listing notice — NextPlat receives Nasdaq bid price deficiency notice; compliance period through Oct 27, 2025
NextPlat Corp
- Common stock closing bid price below $1.00 for 30 consecutive business days triggered Nasdaq deficiency notice on April 28, 2025.
- Company has 180 calendar days (until October 27, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, company may qualify for a second 180-day period by meeting other listing standards and notifying intent to cure.
- CEO cited drug pricing, tariff escalations, and cost reduction efforts as challenges; possible reverse stock split considered.
- Shares continue trading on Nasdaq Capital Market; no immediate delisting effect.